A detailed history of Victory Capital Management Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Victory Capital Management Inc holds 1,928,715 shares of TEVA stock, worth $33 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,928,715
Previous 1,906,951 1.14%
Holding current value
$33 Million
Previous $31 Million 12.16%
% of portfolio
0.04%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$15.81 - $18.96 $344,088 - $412,645
21,764 Added 1.14%
1,928,715 $34.8 Million
Q2 2024

Aug 05, 2024

BUY
$12.78 - $17.4 $1.38 Million - $1.88 Million
107,909 Added 6.0%
1,906,951 $31 Million
Q1 2024

May 03, 2024

BUY
$10.67 - $14.43 $18.8 Million - $25.4 Million
1,760,656 Added 4586.71%
1,799,042 $25.4 Million
Q4 2023

Feb 05, 2024

BUY
$8.12 - $10.63 $55,914 - $73,198
6,886 Added 21.86%
38,386 $400,000
Q3 2023

Nov 06, 2023

SELL
$7.48 - $10.7 $5,595 - $8,003
-748 Reduced 2.32%
31,500 $321,000
Q2 2023

Jul 27, 2023

SELL
$7.2 - $9.47 $59,025 - $77,635
-8,198 Reduced 20.27%
32,248 $242,000
Q1 2023

May 02, 2023

SELL
$8.36 - $11.37 $73,693 - $100,226
-8,815 Reduced 17.89%
40,446 $357,000
Q4 2022

Feb 09, 2023

SELL
$7.95 - $9.48 $1.01 Million - $1.2 Million
-126,499 Reduced 71.97%
49,261 $449,000
Q3 2022

Nov 02, 2022

SELL
$6.86 - $11.95 $109,458 - $190,674
-15,956 Reduced 8.32%
175,760 $1.42 Million
Q2 2022

Aug 01, 2022

BUY
$7.38 - $10.4 $49,165 - $69,284
6,662 Added 3.6%
191,716 $1.44 Million
Q1 2022

May 04, 2022

BUY
$7.33 - $9.39 $399,521 - $511,801
54,505 Added 41.75%
185,054 $1.61 Million
Q4 2021

Feb 07, 2022

BUY
$7.9 - $10.19 $85,722 - $110,571
10,851 Added 9.07%
130,549 $1.05 Million
Q3 2021

Nov 02, 2021

BUY
$8.38 - $10.18 $9,779 - $11,880
1,167 Added 0.98%
119,698 $1.17 Million
Q2 2021

Aug 03, 2021

SELL
$9.9 - $11.56 $204,048 - $238,263
-20,611 Reduced 14.81%
118,531 $1.17 Million
Q1 2021

May 04, 2021

BUY
$10.34 - $12.81 $207,379 - $256,917
20,056 Added 16.84%
139,142 $1.61 Million
Q4 2020

Feb 01, 2021

BUY
$8.61 - $11.04 $308,978 - $396,181
35,886 Added 43.13%
119,086 $1.15 Million
Q3 2020

Nov 09, 2020

BUY
$8.57 - $12.69 $162,307 - $240,335
18,939 Added 29.47%
83,200 $750,000
Q2 2020

Aug 07, 2020

SELL
$8.12 - $13.12 $37,441 - $60,496
-4,611 Reduced 6.7%
64,261 $792,000
Q1 2020

May 04, 2020

SELL
$6.69 - $13.45 $122,567 - $246,417
-18,321 Reduced 21.01%
68,872 $618,000
Q4 2019

Feb 04, 2020

BUY
$6.53 - $10.72 $39,219 - $64,384
6,006 Added 7.4%
87,193 $907,000
Q3 2019

Nov 12, 2019

BUY
$6.16 - $9.6 $500,111 - $779,395
81,187 New
81,187 $559,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.